TWT driver mutations make up the majority (45–58%) of AM cases, with BRAF (10–35%), RAS (8–22%), and NF1 (11–23%) driver mutations making up the rest [27]. The gene discussed is BRAF; the disease is acute myeloblastic leukemia with maturation.